COR VS HCA Stock Comparison
Performance
COR100/100
100/100
COR returned 7.05% in the last 12 months. Based on SPY's performance of -13.80%, its performance is above average giving it a score of 100 of 100.
HCA10/100
10/100
HCA returned 4.32% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Analyst Price Targets
COR68/100
68/100
15 analysts offer 12-month price targets for COR. Together, they have an average target of 171, the most optimistic target put COR at 190 within 12-months and the most pessimistic has COR at 150.
HCA75/100
75/100
22 analysts offer 12-month price targets for HCA. Together, they have an average target of 265.95, the most optimistic target put HCA at 315 within 12-months and the most pessimistic has HCA at 200.
Earnings
COR100/100
100/100
COR has missed earnings 1 times in the last 20 quarters.
HCA10/100
10/100
HCA has missed earnings 6 times in the last 20 quarters.
Profit
COR84/100
84/100
Out of the last 20 quarters, COR has had 20 profitable quarters and has increased their profits year over year on 12 of them.
HCA78/100
78/100
Out of the last 20 quarters, HCA has had 20 profitable quarters and has increased their profits year over year on 10 of them.
Volatility
COR55/100
55/100
COR has had a higher than average amount of volatility over the last 12 months giving it a score of 55 of 100.
HCA49/100
49/100
HCA has had a lower than average amount of volatility over the last 12 months giving it a score of 48 of 100.
Dividend
COR10/100
10/100
COR's most recent dividend was $0.81 per share, based on a share price of $193.22. It was a payout ratio of 182.09% compared to their total earnings.
HCA23/100
23/100
HCA's most recent dividend was $0.35 per share, based on a share price of $237.58. It was a payout ratio of 11.37% compared to their total earnings.
Technicals
COR
"Technicals" not found for COR
HCA50/100
50/100
HCA receives a 50 of 100 based on 14 indicators. 6 are bullish, 6 are bearish.
All score calculations are broken down here to help you make more informed investing decisions
Cencora, Inc. Summary
New York Stock Exchange / COR
Healthcare
Medical - Distribution
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
HCA Healthcare, Inc. Summary
New York Stock Exchange / HCA
Healthcare
Medical - Care Facilities
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare COR to other companies in the same or a similar industry.